Cardiology

Evolocumab doesn't affect cognition when added to statins

(HealthDay)—There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy, according to a study published in the Aug. 17 issue of the New England Journal ...

Cardiology

Statin use among nursing home residents varies significantly

(HealthDay)—Statin prescribing is considerable among nursing home residents, with significant variation in prescribing seen across physicians, according to a study published online Aug. 9 in the Journal of the American ...

Cardiology

Calcium in arteries influences heart attack risk

Patients without calcium buildup in the coronary arteries had significantly lower risk of future heart attack or stroke despite other high risk factors such as diabetes, high blood pressure, or bad cholesterol levels, new ...

Cardiology

Quitting statins after stroke may raise risk of another stroke

Stroke patients who stopped taking statin drugs three to six months after a first ischemic stroke, the type caused by narrowed arteries, had a higher risk of a having another stroke within a year, according to new research ...

Cardiology

Continuing statin after adverse Rx tied to lower cardiac risk

(HealthDay)—For patients with an adverse reaction to a statin, continued statin prescriptions are associated with lower incidence of cardiovascular events and death, according to a study published online July 25 in the ...

page 26 from 40